↓ Skip to main content

Management of acquired resistance to EGFR TKI–targeted therapy in advanced non-small cell lung cancer

Overview of attention for article published in Molecular Cancer, February 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

news
2 news outlets

Citations

dimensions_citation
516 Dimensions

Readers on

mendeley
341 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Management of acquired resistance to EGFR TKI–targeted therapy in advanced non-small cell lung cancer
Published in
Molecular Cancer, February 2018
DOI 10.1186/s12943-018-0777-1
Pubmed ID
Authors

Shang-Gin Wu, Jin-Yuan Shih

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 341 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 341 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 42 12%
Student > Ph. D. Student 38 11%
Student > Master 29 9%
Researcher 23 7%
Other 16 5%
Other 38 11%
Unknown 155 45%
Readers by discipline Count As %
Medicine and Dentistry 56 16%
Biochemistry, Genetics and Molecular Biology 51 15%
Pharmacology, Toxicology and Pharmaceutical Science 18 5%
Agricultural and Biological Sciences 10 3%
Immunology and Microbiology 7 2%
Other 32 9%
Unknown 167 49%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 July 2023.
All research outputs
#2,910,102
of 24,001,212 outputs
Outputs from Molecular Cancer
#173
of 1,800 outputs
Outputs of similar age
#60,311
of 334,193 outputs
Outputs of similar age from Molecular Cancer
#8
of 58 outputs
Altmetric has tracked 24,001,212 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,800 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 334,193 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 58 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.